Trade Summary

1 month ago, Ence Chuck, serving as CAO, COO at Relmada Therapeutics, Inc. (RLMD), purchased 136,000 shares at $2.20 per share, for a total transaction value of $299,200.00. Following this transaction, Ence Chuck now holds 403,931 shares of RLMD.

This purchase represents a 51.00% increase in Ence Chuck's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, November 5, 2025 and publicly disclosed via SEC Form 4 filing on Thursday, November 6, 2025, 1 day after the trade was made.

Relmada Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.